STAGE II NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE II NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE II NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE II NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of two drugs—TG4010 (a vaccine that helps the immune system attack cancer) and nivolumab (an immunotherapy that removes cancer's brakes on immune cells)—in 13 people with advanced non-small cell lung cancer who had already tried other treatments. T…
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated May 17, 2026 08:17 UTC
-
Triple threat: immunotherapy plus chemo and radiation shows promise in lung cancer trial
Disease control CompletedThis early-stage trial tested the safety and best dose of adding the immunotherapy drug pembrolizumab to standard chemotherapy (paclitaxel and carboplatin) and radiation for people with stage II to IIIB non-small cell lung cancer. The goal was to see if this combination could be …
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 14, 2026 12:06 UTC